Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Urology - Case Report

A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate

Authors: Salvatore Giordano, Teemu Tolonen, Tuomo Tolonen, Susanna Hirsimäki, Vesa Kataja

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Abstract

The first time in Scandinavia we present a case report of a pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Our patient is a 34-year-old male with a long history of symptomatic chronic prostatitis/prostatodynia. After developing severe obstructive uropathy, a transurethral resection was performed. An unexpected diagnosis of a low-grade neuroendocrine carcinoma was made. Subsequently, in radical prostatovesiculectomy, we noted metastases to both seminal vesicles and two inguinal lymph nodes. Follow up is ongoing.
Literature
1.
go back to reference Dauge MC, Grossin M, Doumecq-Lacoste JM et al (1985) Carcinoid tumor of the prostate: a new anatomical case and review of the literature. Arch Anat Cytol Pathol 33:73–79PubMed Dauge MC, Grossin M, Doumecq-Lacoste JM et al (1985) Carcinoid tumor of the prostate: a new anatomical case and review of the literature. Arch Anat Cytol Pathol 33:73–79PubMed
2.
go back to reference Ketata S, Ketata H, Fakhfakh H et al (2006) Pure primary neuroendocrine tumor of the prostate: a rare entity. Clin Genitourin Cancer 5:82–84CrossRefPubMed Ketata S, Ketata H, Fakhfakh H et al (2006) Pure primary neuroendocrine tumor of the prostate: a rare entity. Clin Genitourin Cancer 5:82–84CrossRefPubMed
3.
go back to reference Lim KH, Huang MJ, Yang S et al (2005) Primary carcinoid tumor of prostate presenting with bone marrow metastases. Urology 65:174.e9–174.e11CrossRef Lim KH, Huang MJ, Yang S et al (2005) Primary carcinoid tumor of prostate presenting with bone marrow metastases. Urology 65:174.e9–174.e11CrossRef
4.
go back to reference Reyes A, Moran CA (2004) Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Arch Pathol Lab Med 128:e166–e168PubMed Reyes A, Moran CA (2004) Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate. Arch Pathol Lab Med 128:e166–e168PubMed
5.
go back to reference Sciarra A, Mariotti G et al (2008) Prostate growth and inflammation. J Steroid Biochem Mol Biol 108:254–260CrossRefPubMed Sciarra A, Mariotti G et al (2008) Prostate growth and inflammation. J Steroid Biochem Mol Biol 108:254–260CrossRefPubMed
8.
go back to reference West NE, Wise PE et al (2007) Carcinoid tumors are 15 times more common in patients with Crohn’s disease. Inflamm Bowel Dis 13:1129–1134CrossRefPubMed West NE, Wise PE et al (2007) Carcinoid tumors are 15 times more common in patients with Crohn’s disease. Inflamm Bowel Dis 13:1129–1134CrossRefPubMed
9.
go back to reference Whelan T, Gatfield CT, Robertson S et al (1995) Primary carcinoid of the prostate in conjuction with multiple endocrine neoplasia IIb in a child. J Urol 153:1080–1082CrossRefPubMed Whelan T, Gatfield CT, Robertson S et al (1995) Primary carcinoid of the prostate in conjuction with multiple endocrine neoplasia IIb in a child. J Urol 153:1080–1082CrossRefPubMed
10.
go back to reference Zarkovic A, Masters J, Carpenter L (2005) Primary carcinoid tumour of the prostate. Pathology 37:184–186CrossRefPubMed Zarkovic A, Masters J, Carpenter L (2005) Primary carcinoid tumour of the prostate. Pathology 37:184–186CrossRefPubMed
Metadata
Title
A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
Authors
Salvatore Giordano
Teemu Tolonen
Tuomo Tolonen
Susanna Hirsimäki
Vesa Kataja
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9660-8

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.